Continuous adjustment of the concept of innovative drugs, Nanjing Pharmaceutical falls more than 10%.

The concept of innovative drugs continues to adjust, with South Pharmaceutical, Rejing Biology falling by more than 10%, Borui Medicine, Menova, Yuandong Biology, Shutaishen, and Medisite all falling by more than 5%.